NASDAQ : SLN

Silence Therapeutics plc — Financial statements

Healthcare · Biotechnology · United Kingdom

Last price 19.75 USD (Oct 30, 2026, 3:17 PM EDT) · Market cap 1.19B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Silence Therapeutics plc (SLN) reported revenue of 615.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue615.00K559.00K43.26M31.64M21.66M16.81M
Cost of Revenue87.00K215.00K11.81M12.87M13.46M10.10M
Gross Profit528.00K344.00K31.45M18.78M8.19M6.71M
Selling, General & Admin21.27M22.34M26.88M26.22M25.68M27.09M
Research & Development43.68M60.29M54.15M44.99M33.73M41.66M
Operating Expenses64.95M82.63M81.03M71.21M59.41M68.75M
Operating Income-64.42M-82.29M-49.58M-52.43M-51.22M-62.03M
Interest Expense-10.83K
Interest & Investment Income15.00K15.00K704.00K13.54K
Currency Exchange Gain (Loss)1.58M-8.47M646.00K-2.64M1.29M-59.58K
Other Non Operating Income (Expenses)2.88M3.46M3.77M1.80M280.00K
EBT Excluding Unusual Items-59.95M-87.28M-44.46M-53.27M-49.65M-62.09M
Merger & Restructuring Charges-1.32M
Pretax Income-59.95M-88.60M-44.46M-53.27M-49.65M-62.09M
Income Tax Expense2.00K11.00K845.00K956.00K688.00K-8.73M
Net Income-59.95M-88.61M-45.31M-54.23M-50.33M-53.36M
Net Income to Common-59.95M-88.61M-45.31M-54.23M-50.33M-53.36M
Shares Outstanding (Basic)47.23M47.23M46.25M37.09M32.19M29.65M
Shares Outstanding (Diluted)47.23M47.23M46.25M37.09M32.19M29.65M
EPS (Basic)-1.27-1.88-0.98-1.46-1.56-1.80
EPS (Diluted)-1.27-1.88-0.98-1.46-1.56-1.80
Free Cash Flow-42.27M-62.33M-67.85M-49.52M-57.22M7.44M
Free Cash Flow Per Share-0.90-1.32-1.47-1.33-1.780.25
Gross Margin85.85%61.54%72.70%59.34%37.83%39.94%
Operating Margin-10,475.61%-14,720.93%-114.62%-165.70%-236.53%-369.02%
Profit Margin-9,748.45%-15,851.88%-104.74%-171.37%-232.44%-317.44%
Free Cash Flow Margin-6,872.52%-11,149.55%-156.85%-156.49%-264.22%44.26%
EBITDA-63.94M-81.73M-48.99M-51.81M-50.62M-61.69M
EBITDA Margin-113.25%-163.74%-233.78%
D&A For EBITDA483.00K555.00K593.00K621.00K596.00K343.93K
EBIT-64.42M-82.29M-49.58M-52.43M-51.22M-62.03M
EBIT Margin-114.62%-165.70%-236.53%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents72.05M11.28M121.33M68.79M66.05M99.57M
Short-Term Investments73.84M26.00M19.67M
Cash & Short-Term Investments72.05M85.11M147.33M68.79M85.72M99.57M
Accounts Receivable972.00K290.00K1.10M448.19K
Other Receivables9.29M24.61M25.94M23.69M19.79M11.04M
Receivables9.29M24.61M26.91M23.98M20.90M11.49M
Prepaid Expenses8.93M13.12M10.38M9.88M5.83M
Other Current Assets12.94M
Total Current Assets94.28M118.66M187.37M103.15M116.50M116.90M
Property, Plant & Equipment1.44M1.75M1.98M2.31M2.65M2.63M
Long-Term Investments342.19K407.57K
Goodwill10.32M10.62M9.39M9.98M9.65M10.28M
Other Intangible Assets237.00K288.00K312.00K362.00K385.56K32.50K
Other Long-Term Assets127.00K127.00K3.59M3.65M
Total Assets106.41M131.44M202.63M119.45M129.53M130.25M
Accounts Payable12.61M4.41M3.70M3.35M3.84M5.50M
Accrued Expenses8.91M12.05M11.71M10.67M8.85M
Current Portion of Leases103.00K89.00K117.00K228.00K537.38K185.51K
Current Income Taxes Payable39.00K652.00K474.00K709.68K250.50K
Current Unearned Revenue168.00K306.00K6.57M10.68M5.75M
Total Current Liabilities12.71M13.61M16.82M22.34M26.44M20.54M
Long-Term Leases9.00K71.00K118.00K
Long-Term Unearned Revenue55.22M55.45M51.79M75.00M76.49M98.17M
Total Liabilities67.94M69.14M68.61M97.45M102.93M118.71M
Common Stock10.29M10.29M10.29M8.85M6.49M6.08M
Additional Paid-In Capital621.15M617.56M609.56M455.76M273.11M249.60M
Retained Earnings-592.97M-562.57M-474.04M-431.89M-317.20M-301.91M
Comprehensive Income & Other-2.98M-11.78M-10.72M64.19M57.78M
Shareholders' Equity38.47M62.30M134.02M21.99M26.59M11.54M
Total Liabilities & Equity106.41M131.44M202.63M119.45M129.53M130.25M
Total Debt112.00K160.00K117.00K346.00K537.38K185.51K
Net Cash (Debt)71.94M84.95M147.22M68.44M85.18M99.39M
Net Cash Per Share1.521.803.181.852.653.35
Filing Date Shares Outstanding47.25M47.23M47.22M46.50M35.95M29.93M
Total Common Shares Outstanding47.25M47.23M47.22M39.62M35.94M29.93M
Working Capital81.57M105.05M170.54M80.81M90.06M96.36M
Book Value Per Share0.811.322.840.560.740.39
Tangible Book Value27.91M51.40M124.32M11.65M16.56M1.23M
Tangible Book Value Per Share0.591.092.630.290.460.04
Machinery5.54M6.34M6.44M6.01M6.92M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-59.95M-88.61M-45.31M-54.23M-50.33M-53.36M
Depreciation & Amortization483.00K555.00K593.00K621.00K596.00K578.18K
Stock-Based Compensation6.20M8.07M16.31M16.27M12.69M11.69M
Other Operating Activities-3.29M7.55M-6.21M3.12M-595.00K-2.29M
Change in Accounts Receivable92.00K1.02M-904.00K392.00K-723.00K37.21M
Change in Accounts Payable-1.44M-4.08M499.00K-473.00K2.02M3.26M
Change in Unearned Revenue-524.00K-334.00K-28.79M-10.32M-5.44M11.33M
Change in Other Net Operating Assets16.16M13.55M-3.83M-4.84M-15.26M796.19K
Operating Cash Flow-42.26M-62.27M-67.64M-49.46M-57.04M9.22M
Capital Expenditures-3.00K-55.00K-211.00K-56.00K-173.00K-1.78M
Sale (Purchase) of Intangibles-372.00K-31.14K
Investment in Securities72.89M-47.94M-21.75M19.35M-19.95M13.54M
Other Investing Activities13.54K
Investing Cash Flow72.89M-47.99M-21.97M19.29M-20.50M11.75M
Long-Term Debt Repaid-285.71K
Lease Payments-285.71K
Net Debt Issued (Repaid)-285.71K
Issuance of Common Stock2.00K15.00K142.09M31.94M52.58M41.87M
Financing Cash Flow2.00K15.00K142.09M31.94M52.58M41.58M
Foreign Exchange Rate Adjustments-315.00K195.00K60.00K749.00K-8.12M-142.18K
Net Cash Flow30.32M-110.05M52.54M2.52M-33.08M62.41M
Free Cash Flow-42.27M-62.33M-67.85M-49.52M-57.22M7.44M
Free Cash Flow Margin-6,872.52%-11,149.55%-156.85%-156.49%-264.22%44.26%
Free Cash Flow Per Share-0.90-1.32-1.47-1.33-1.780.25
Levered Free Cash Flow-23.57M-39.55M-25.37M-23.31M-26.84M-6.72M
Unlevered Free Cash Flow-23.57M-39.55M-25.37M-23.31M-26.84M-6.71M
Free Cash Flow After Leases-42.27M-62.33M-67.85M-49.52M-57.22M7.15M
Cash Income Tax Paid300.00K637.00K433.00K801.00K
Change in Working Capital14.29M10.16M-33.02M-15.24M-19.40M52.60M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization1.19B287.18M324.84M671.70M547.37M714.99M
Enterprise Value1.12B185.17M152.14M600.31M447.62M611.92M
Last Close Price19.766.086.8817.3715.2523.89
PS Ratio1,934.53513.747.5121.2325.2842.53
PB Ratio24.274.612.4230.5420.5861.93
P/TBV Ratio42.635.592.6157.6633.06580.25
P/FCF Ratio96.09
P/OCF Ratio77.58
EV/Sales Ratio1,817.55331.263.5218.9720.6736.40
EV/FCF Ratio82.24
Debt / Equity Ratio0.000.000.000.020.020.02
Debt / FCF Ratio0.03
Net Debt / Equity Ratio-1.87-1.36-1.10-3.11-3.20-8.61
Net Debt / EBITDA Ratio1.121.043.001.321.681.61
Net Debt / FCF Ratio1.701.362.171.381.49-13.36
Asset Turnover0.010.000.270.250.180.14
Quick Ratio6.408.0610.364.154.035.41
Current Ratio7.428.7211.144.624.415.69
Return on Equity (ROE)-90.41%-90.27%-58.08%-223.22%-273.06%-448.22%
Return on Assets (ROA)-29.65%-30.79%-19.24%-26.32%-26.09%-31.44%
Return on Capital Employed (ROCE)-68.80%-69.80%-26.70%-54.00%-49.70%-56.50%
Earnings Yield-19.27%-30.86%-13.95%-8.07%-9.20%-7.46%
FCF Yield-3.55%-21.70%-20.89%-7.37%-10.45%1.04%
Buyback Yield / Dilution-0.09%-2.12%-24.69%-15.21%-8.58%-8.78%